drugset / Trial / NCT02035111
A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
Phase 4
Completed
947 enrolled
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd. · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and the efficacy of Tianshu capsule treating Migraine Headache.
Timeline
- Start
- 2014-03
- Primary completion
- 2015-04
- Completion
- 2015-11
Outcome
Met primary endpoint
paper Following the 12-week treatment, significant improvement was observed in the TSC group concerning both primary and secondary outcomes. PMID 31842860 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tianshu capsule | Traditional medicine (herbal / TCM) | 1.36 g | Oral |